US Patent 7,723,036
United States Patent and Trademark Office
University of Iowa Research Foundation (Iowa City, IA, US)
The present invention encompasses methods for predicting metastasis in cancer by assessing the structure of the complement protein C1qA. The methods may encompass examining either protein or nucleic acids, and may further include making treatment decisions based on the predictive methods.
Racila, Emilian V. and Weiner, George J. Assessing response to anti-CD20 therapy by genotyping C1q components. US Patent 7,723,036 filed August 17, 2006 and issued May 25, 2010. https://ir.uiowa.edu/patents/510